ABCG1 and nonpapillary renal cell carcinoma: The six MDGs (ABCG1, HAVCR2, CD14, TGFA, KDF1, and KITLG) we identified in this study were significantly associated with ccRCC patient outcomes and therefore may play an important role in disease progression.